Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Iron deficiency anemia is significantly linked to hair loss in childbearing women, and taking iron improves the condition.

Telogen effluvium is a condition that causes temporary hair loss.

A woman had temporary hair loss due to stress from a spinal cord injury.

The document's conclusion cannot be determined from the provided text.

Telogen effluvium is a condition that causes temporary hair loss.

Telogen effluvium is a condition that causes temporary hair loss.

The document's conclusion cannot be provided because the document cannot be parsed.

The supplement effectively improved hair growth and reduced hair loss safely.

Early diagnosis and personalized treatment are crucial for managing hair loss in India.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Changing estrogen levels during menopause might affect genes related to body rhythms and cause increased hair loss.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Chronic telogen effluvium is a condition that causes ongoing hair shedding.

The supplement significantly improves hair density and appearance in people with hair loss.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

Serum ferritin is a better indicator than hemoglobin for detecting low iron in women with chronic hair loss.

A simple method using the wash test and dermatoscopy can help differentiate between two hair loss conditions, androgenetic alopecia and chronic telogen effluvium.

No significant difference in iron deficiency between women with or without hair loss.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

The document's conclusion cannot be provided because the content is not in a processable format.

Low levels of certain trace elements might contribute to hair loss in Egyptian women.

Poor nutrition is linked to increased hair loss in Canadian children.

The study found that it's hard to tell the difference between two types of hair loss, alopecia areata and telogen effluvium, by looking at symptoms and tissue samples.

Hair casts may be a useful clue for diagnosing hair loss during the resting phase of hair growth.

Hair loss at the site where hair was taken for a transplant can be due to the normal hair growth cycle.

High ferritin levels might be linked to chronic hair loss.

Telogen effluvium most affects quality of life in alopecia patients.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.